Morgan Stanley’s Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 CNDA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-180,000
Closed -$19.8K 8092
2024
Q2
$19.8K Hold
180,000
﹤0.01% 6466
2024
Q1
$20K Sell
180,000
-180,000
-50% -$21.6K ﹤0.01% 6488
2023
Q4
$46.8K Buy
+360,000
New +$59.4K ﹤0.01% 6406

Other funds holding CNDA.WS

Morgan Stanley's CNDA.WS Position: Q3 2024 in Review

Morgan Stanley sold out of Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (CNDA.WS) in Q3 2024, closing a stake of 180,000 shares — an estimated $19.8K sold.

Morgan Stanley first reported a position in CNDA.WS in Q4 2023 and held it in 3 quarters. The position peaked at $46.8K in Q4 2023. 5 funds tracked by Wall St. Rank hold CNDA.WS as of Q3 2024.

  • Morgan Stanley reported no remaining Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q3 2024 after selling out during the quarter.
  • Morgan Stanley sold 180,000 Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q3 2024, an estimated $19.8K.
  • Morgan Stanley first reported a position in Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q4 2023 and held it in 3 quarters.
  • Morgan Stanley's Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $46.8K in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q3 2024.

Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.